Medicare Enrolled

Dr. James Zu, M.D., PH.D

Neurology · Edison, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3 PROGRESS STREET, Edison, NJ 08820
9087565733
In practice since 2006 (19 years)
NPI: 1083787824 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Zu

Dr. James Zu is a neurology specialist in Edison, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Zu performed 633 Medicare services across 371 unique beneficiaries.

Between the years covered by Open Payments, Dr. Zu received a total of $6,951 from 44 pharmaceutical and/or device companies across 530 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Zu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 50% volume in NJ $6,951 industry payments

Medicare Practice Summary

Medicare Utilization ↗
633
Medicare services
Top 50% in NJ for neurology
371
Unique beneficiaries
$135
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~33 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
371 $100 $300
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
65 $146 $350
Digital analysis of brain wave activity (EEG)
This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision.
36 $252 $900
EEG brain wave test, 61-119 minutes
This procedure measures electrical activity in the brain using electrodes placed on the scalp. It records brain wave patterns for a duration between 61 and 119 minutes.
35 $388 $900
New patient office visit, complex (60-74 min) 32 $191 $550
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
25 $89 $300
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
23 $57 $250
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
18 $129 $450
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
17 $88 $300
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
11 $255 $900
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,951
Total received (2018-2024)
Avg $993/year across 7 years
Top 29% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
530
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,607 (95.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$306 (4.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,580
2023
$1,525
2022
$1,064
2021
$802
2020
$603
2019
$767
2018
$609

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$482
ABBVIE INC.
$344
Lilly USA, LLC
$210
ARGENX US, INC.
$116
PFIZER INC.
$93
Biogen, Inc.
$74
Eisai Inc.
$62
Teva Pharmaceuticals USA, Inc.
$47
Neurocrine Biosciences, Inc.
$29
Takeda Pharmaceuticals U.S.A., Inc.
$22
Abbott Laboratories
$20
Aucta Pharmaceuticals, Inc.
$20
CSL Behring
$18
Amneal Pharmaceuticals LLC
$15
Celgene Corporation
$15
EMD Serono, Inc.
$15
Top 3 companies account for 65.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,701
Biogen, Inc.
$1,091
ABBVIE INC.
$498
Lilly USA, LLC
$383
Teva Pharmaceuticals USA, Inc.
$368
UCB, Inc.
$348
PFIZER INC.
$229
AbbVie Inc.
$206
Biohaven Pharmaceutical Holding Company Ltd.
$173
ARGENX US, INC.
$167
GENZYME CORPORATION
$152
Supernus Pharmaceuticals, Inc.
$146
Alexion Pharmaceuticals, Inc.
$146
CSL Behring
$129
Boehringer Ingelheim Pharmaceuticals, Inc.
$125
Eisai Inc.
$113
Genentech USA, Inc.
$113
Amneal Pharmaceuticals LLC
$103
Neurocrine Biosciences, Inc.
$69
Impax Laboratories, Inc.
$67
Amgen Inc.
$66
Biohaven Pharmaceuticals, Inc.
$54
Acorda Therapeutics, Inc
$52
Allergan, Inc.
$49
Avanir Pharmaceuticals, Inc.
$44
ACADIA Pharmaceuticals Inc
$39
Celgene Corporation
$32
EMD Serono, Inc.
$26
CATALYST PHARMACEUTICALS, INC.
$25
SK Life Science, Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$22
Abbott Laboratories
$20
Aucta Pharmaceuticals, Inc.
$20
Avion Pharmaceuticals
$15
Lundbeck LLC
$15
Bayer HealthCare Pharmaceuticals Inc.
$15
Grifols USA, LLC
$14
IMPEL PHARMACEUTICALS INC.
$14
Kyowa Kirin, Inc.
$14
EISAI INC.
$14
Allergan Inc.
$13
Mallinckrodt LLC
$12
Neurelis, Inc.
$12
US WorldMeds, LLC
$11
Top 3 companies account for 47.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · Betaseron · Briviact · COPAXONE · Dhivy · EMGALITY · FIRDAPSE · Fycompa · GILENYA · Gamunex-C · HYQVIA · Hizentra · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · Leqembi · MAYZENT · MYOBLOC · Mavenclad · Motpoly XR · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · OCREVUS · OFEV · ONGENTYS 50MG CAPSULES 30 · OXTELLAR XR · Ocrevus · PANZYGA · PAXLOVID · QULIPTA · RYTARY · SOLIRIS · Soliris · TECFIDERA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Edison?
Compare neurologists in the Edison area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
667
Per 100K population
77.4
County median income
$109,028
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
4.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Zu is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Zu experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Zu performed 371 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zu receive payments from pharmaceutical companies?
Yes. Dr. Zu received a total of $6,951 from 44 companies across 530 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zu's costs compare to other neurologists in Edison?
Dr. Zu's average Medicare payment per service is $135. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →